Clinical Trial Update: Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Utidelone in combination with Capecitabine for metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer Recurrent

Drugs mentioned

• Capecitabine (capecitabine)
• Utidelone (utidelone)

Snippet

Sponsor: Min Yan, MD | Conditions: Breast Cancer Recurrent | Phase 2 | Status: RECRUITING